Research progress on radical concurrent chemoradiotherapy for locally advanced esophageal cancer / 中华放射肿瘤学杂志
Chinese Journal of Radiation Oncology
;
(6): 1065-1069, 2022.
Article
Dans Chinois
| WPRIM
| ID: wpr-956955
ABSTRACT
The current standard treatment modality for unresectable locally advanced esophageal cancer is radical concurrent chemoradiotherapy. In this article, research progress on radiotherapy techniques, differences in radiotherapy dose and target volume, exploration in concurrent chemotherapy and immunotherapy was reviewed, aiming to provide reference and evidence for clinical treatment.
Texte intégral:
Disponible
Indice:
WPRIM (Pacifique occidental)
langue:
Chinois
Texte intégral:
Chinese Journal of Radiation Oncology
Année:
2022
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS